Guardant Health (GH) Receivables - Net (2017 - 2026)
Guardant Health's Receivables - Net history spans 9 years, with the latest figure at $137.8 million for Q4 2025.
- On a quarterly basis, Receivables - Net rose 25.03% to $137.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $137.8 million, a 25.03% increase, with the full-year FY2025 number at $137.8 million, up 25.03% from a year prior.
- Receivables - Net hit $137.8 million in Q4 2025 for Guardant Health, up from $115.6 million in the prior quarter.
- Over the last five years, Receivables - Net for GH hit a ceiling of $137.8 million in Q4 2025 and a floor of $48.0 million in Q1 2021.
- Historically, Receivables - Net has averaged $92.9 million across 5 years, with a median of $88.8 million in 2023.
- Biggest five-year swings in Receivables - Net: surged 83.22% in 2021 and later dropped 9.24% in 2023.
- Tracing GH's Receivables - Net over 5 years: stood at $97.7 million in 2021, then dropped by 0.41% to $97.3 million in 2022, then dropped by 8.71% to $88.8 million in 2023, then grew by 24.18% to $110.3 million in 2024, then rose by 25.03% to $137.8 million in 2025.
- Business Quant data shows Receivables - Net for GH at $137.8 million in Q4 2025, $115.6 million in Q3 2025, and $130.3 million in Q2 2025.